550 related articles for article (PubMed ID: 12691620)
21. Toll and Toll-like proteins: an ancient family of receptors signaling infection.
Imler JL; Hoffmann JA
Rev Immunogenet; 2000; 2(3):294-304. PubMed ID: 11256741
[TBL] [Abstract][Full Text] [Related]
22. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling.
de Veer MJ; Curtis JM; Baldwin TM; DiDonato JA; Sexton A; McConville MJ; Handman E; Schofield L
Eur J Immunol; 2003 Oct; 33(10):2822-31. PubMed ID: 14515266
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptors (TLRs) signalling and expression pattern.
Muzio M; Mantovani A
J Endotoxin Res; 2001; 7(4):297-300. PubMed ID: 11717585
[TBL] [Abstract][Full Text] [Related]
24. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2.
Yang RB; Mark MR; Gurney AL; Godowski PJ
J Immunol; 1999 Jul; 163(2):639-43. PubMed ID: 10395652
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
26. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6.
Kawai T; Sato S; Ishii KJ; Coban C; Hemmi H; Yamamoto M; Terai K; Matsuda M; Inoue J; Uematsu S; Takeuchi O; Akira S
Nat Immunol; 2004 Oct; 5(10):1061-8. PubMed ID: 15361868
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis.
Singh JC; Cruickshank SM; Newton DJ; Wakenshaw L; Graham A; Lan J; Lodge JP; Felsburg PJ; Carding SR
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G514-24. PubMed ID: 15499080
[TBL] [Abstract][Full Text] [Related]
28. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily.
O'Neill LA
Curr Top Microbiol Immunol; 2002; 270():47-61. PubMed ID: 12467243
[TBL] [Abstract][Full Text] [Related]
29. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression.
Vogel SN; Fitzgerald KA; Fenton MJ
Mol Interv; 2003 Dec; 3(8):466-77. PubMed ID: 14993454
[TBL] [Abstract][Full Text] [Related]
30. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.
Hoebe K; Du X; Georgel P; Janssen E; Tabeta K; Kim SO; Goode J; Lin P; Mann N; Mudd S; Crozat K; Sovath S; Han J; Beutler B
Nature; 2003 Aug; 424(6950):743-8. PubMed ID: 12872135
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3.
Huang Q; Yang J; Lin Y; Walker C; Cheng J; Liu ZG; Su B
Nat Immunol; 2004 Jan; 5(1):98-103. PubMed ID: 14661019
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.
Xu Y; Tao X; Shen B; Horng T; Medzhitov R; Manley JL; Tong L
Nature; 2000 Nov; 408(6808):111-5. PubMed ID: 11081518
[TBL] [Abstract][Full Text] [Related]
33. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.
O'Neill LA; Bowie AG
Nat Rev Immunol; 2007 May; 7(5):353-64. PubMed ID: 17457343
[TBL] [Abstract][Full Text] [Related]
34. Signalling adaptors used by Toll-like receptors: an update.
Kenny EF; O'Neill LA
Cytokine; 2008 Sep; 43(3):342-9. PubMed ID: 18706831
[TBL] [Abstract][Full Text] [Related]
35. TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferons.
Seya T; Oshiumi H; Sasai M; Akazawa T; Matsumoto M
Int J Biochem Cell Biol; 2005 Mar; 37(3):524-9. PubMed ID: 15618008
[TBL] [Abstract][Full Text] [Related]
36. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
Dunne A; O'Neill LA
Sci STKE; 2003 Feb; 2003(171):re3. PubMed ID: 12606705
[TBL] [Abstract][Full Text] [Related]
37. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
Martin MU; Wesche H
Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
[TBL] [Abstract][Full Text] [Related]
38. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
[TBL] [Abstract][Full Text] [Related]
39. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
[TBL] [Abstract][Full Text] [Related]
40. A unique feature of Toll/IL-1 receptor domain-containing adaptor protein is partially responsible for lipopolysaccharide insensitivity in zebrafish with a highly conserved function of MyD88.
Liu Y; Li M; Fan S; Lin Y; Lin B; Luo F; Zhang C; Chen S; Li Y; Xu A
J Immunol; 2010 Sep; 185(6):3391-400. PubMed ID: 20702732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
